• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Does Endometriosis Hinder Successful Ovarian Debulking Surgery?子宫内膜异位症会妨碍卵巢减瘤手术的成功进行吗?
Asian Pac J Cancer Prev. 2018 Feb 26;19(2):509-512. doi: 10.22034/APJCP.2018.19.2.509.
2
Unexpected epithelial ovarian cancers arising from presumed endometrioma: A 10-year retrospective analysis.源自假定子宫内膜异位囊肿的意外上皮性卵巢癌:一项10年回顾性分析。
Taiwan J Obstet Gynecol. 2017 Feb;56(1):55-61. doi: 10.1016/j.tjog.2015.09.009.
3
[Risk factors of endometriosis associated ovarian carcinoma in women aged 45 years and older].[45岁及以上女性子宫内膜异位症相关卵巢癌的危险因素]
Zhonghua Fu Chan Ke Za Zhi. 2017 May 25;52(5):314-319. doi: 10.3760/cma.j.issn.0529-567X.2017.05.005.
4
Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer.晚期上皮性卵巢癌和腹膜癌行膈肌手术肿瘤减灭术的成功率及安全性
Arch Gynecol Obstet. 2015 Mar;291(3):641-6. doi: 10.1007/s00404-014-3446-7. Epub 2014 Sep 4.
5
Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.子宫内膜异位症相关卵巢癌(EAOC):一项巢式病例对照研究表明,它是一种与其他卵巢癌不同的实体。
Gynecol Oncol. 2001 Oct;83(1):100-8. doi: 10.1006/gyno.2001.6382.
6
A study of clinicopathologic factors as indicators for early prediction of suboptimal debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer.一项关于临床病理因素作为晚期卵巢癌新辅助化疗后次优减瘤手术早期预测指标的研究。
J Obstet Gynaecol Res. 2018 Jul;44(7):1294-1301. doi: 10.1111/jog.13653. Epub 2018 Apr 23.
7
Differentiation between endometriosis-associated ovarian cancers and non- endometriosis-associated ovarian cancers based on magnetic resonance imaging.基于磁共振成像的子宫内膜异位症相关卵巢癌与非子宫内膜异位症相关卵巢癌的鉴别。
Br J Radiol. 2021 Sep 1;94(1125):20201441. doi: 10.1259/bjr.20201441. Epub 2021 Apr 29.
8
Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection.优化卵巢癌治疗:新辅助化疗和间隔肿瘤缩小术与初始肿瘤细胞减灭术治疗可能无法实现理想切除的上皮性卵巢癌。
Gynecol Oncol. 2017 Feb;144(2):266-273. doi: 10.1016/j.ygyno.2016.11.021. Epub 2016 Dec 1.
9
Endometriosis-associated Ovarian Cancer: A Distinct Clinical Entity?子宫内膜异位症相关的卵巢癌:一种独特的临床实体?
Anticancer Res. 2016 Jul;36(7):3445-9.
10
Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients.原发性手术效果欠佳会导致卵巢癌患者出现不良免疫变化。
Immunobiology. 2018 Jan;223(1):1-7. doi: 10.1016/j.imbio.2017.10.021. Epub 2017 Oct 5.

引用本文的文献

1
Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance.子宫内膜异位症相关卵巢癌:从分子病理学至临床相关性
Int J Mol Sci. 2024 Apr 13;25(8):4306. doi: 10.3390/ijms25084306.
2
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.与卵巢癌初次细胞减灭术后存在大体残留病灶相关的生活方式和个人因素。
Gynecol Oncol. 2023 Jan;168:68-75. doi: 10.1016/j.ygyno.2022.10.018. Epub 2022 Nov 17.

本文引用的文献

1
Clear cell ovarian cancer and endometriosis: is there a relationship?透明细胞卵巢癌与子宫内膜异位症:它们之间有关系吗?
Prz Menopauzalny. 2016 Jun;15(2):85-9. doi: 10.5114/pm.2016.61190. Epub 2016 Jul 22.
2
Role of aggressive surgical cytoreduction in advanced ovarian cancer.积极的手术细胞减灭术在晚期卵巢癌中的作用。
J Gynecol Oncol. 2015 Oct;26(4):336-42. doi: 10.3802/jgo.2015.26.4.336. Epub 2015 Jul 17.
3
Effect of Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma: A Two-Center Cohort Study and Meta-analysis.子宫内膜异位症对卵巢透明细胞癌预后的影响:一项两中心队列研究和荟萃分析
Ann Surg Oncol. 2015 Aug;22(8):2738-45. doi: 10.1245/s10434-014-4319-9. Epub 2015 Feb 14.
4
Comparative study of ovarian clear cell carcinoma with and without endometriosis in People's Republic of China.中华人民共和国子宫内膜异位症相关与非相关卵巢透明细胞癌的对比研究。
Fertil Steril. 2014 Dec;102(6):1656-62. doi: 10.1016/j.fertnstert.2014.08.008. Epub 2014 Sep 23.
5
Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.子宫内膜异位症患者的卵巢癌风险和预后:一项荟萃分析。
Br J Cancer. 2014 Apr 2;110(7):1878-90. doi: 10.1038/bjc.2014.29. Epub 2014 Feb 11.
6
ESHRE guideline: management of women with endometriosis.ESHRE 指南:子宫内膜异位症女性的管理。
Hum Reprod. 2014 Mar;29(3):400-12. doi: 10.1093/humrep/det457. Epub 2014 Jan 15.
7
The relation between endometriosis and ovarian cancer - a review.子宫内膜异位症与卵巢癌的关系 - 综述。
Acta Obstet Gynecol Scand. 2014 Jan;93(1):20-31. doi: 10.1111/aogs.12255. Epub 2013 Oct 9.
8
The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey.内异症对身体、心理和社会健康的重大影响:一项国际横断面调查的结果。
Hum Reprod. 2013 Oct;28(10):2677-85. doi: 10.1093/humrep/det284. Epub 2013 Jul 11.
9
Major clinical research advances in gynecologic cancer in 2012.2012 年妇科癌症的主要临床研究进展。
J Gynecol Oncol. 2013 Jan;24(1):66-82. doi: 10.3802/jgo.2013.24.1.66. Epub 2013 Jan 8.
10
Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects.子宫内膜异位症与卵巢癌:临床、病理和分子方面的综述。
Int J Gynecol Pathol. 2011 Nov;30(6):553-68. doi: 10.1097/PGP.0b013e31821f4b85.

子宫内膜异位症会妨碍卵巢减瘤手术的成功进行吗?

Does Endometriosis Hinder Successful Ovarian Debulking Surgery?

作者信息

Sananpanichkul Panya, Muangtan Supanee, Suknikhom Wineeya, Bhamarapravatana Kornkarn, Suwannarurk Komsun

机构信息

Department of Obstetrics and Gynecology, Prapokklao hospital, Chanthaburi, Thailand. Email:

出版信息

Asian Pac J Cancer Prev. 2018 Feb 26;19(2):509-512. doi: 10.22034/APJCP.2018.19.2.509.

DOI:10.22034/APJCP.2018.19.2.509
PMID:29480993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5980942/
Abstract

Background: Endometriosis has a significant effect on many aspects of women’s lives, also increasing the risk of ovarian cancer. Although endometriosis is considered as a benign condition, it sometimes behaves like cancer. Methods: All medical records of epithelial ovarian cancer patients during January 2011 to December 2016 were reviewed. Recurrent cases were excluded. Data collected included age at diagnosis, parity, marital status, familial history of cancer, menopausal status, weight, height, smoking histroy, contraception, CA 125 level, result of surgery and pathological report. Results: One hundred and seventy-two medical records of patients with epithelial ovarian cancer (EOC) were included. Average age at diagnosis was 52.3 years. Epithelial ovarian cancer coexisting with endometriosis (EAOC) was found in nearly one-fifth of cases. Nullipara and smoking were associated with 2.3 and 8.3 fold higher risk of EAOC development (aOR 2.349, 95%CI 1.012-5.451; aOR 8.26, 95%CI 1.234-55.278; respectively). Age, familial history of cancer and coexistence with endometriosis were factors related to surgical outcome. More of EAOC group had optimal surgery compared to the non-EAOC group (61.3% and 41.8%) with statistical significance. Conclusion: Younger age, familial history of cancer and coexistence of endometriosis were factors related to optimal surgery. Success of optimal surgery is greater in EAOC than in non-EAOC patients. Coexistence of endometriosis does not hinder successful ovarian cancer debulking surgery.

摘要

背景

子宫内膜异位症对女性生活的诸多方面有重大影响,还会增加卵巢癌风险。尽管子宫内膜异位症被视为一种良性疾病,但它有时表现得像癌症。方法:回顾了2011年1月至2016年12月期间上皮性卵巢癌患者的所有病历。排除复发病例。收集的数据包括诊断时的年龄、生育情况、婚姻状况、癌症家族史、绝经状态、体重、身高、吸烟史、避孕情况、CA 125水平、手术结果和病理报告。结果:纳入了172例上皮性卵巢癌(EOC)患者的病历。诊断时的平均年龄为52.3岁。近五分之一的病例中发现上皮性卵巢癌与子宫内膜异位症共存(EAOC)。未生育和吸烟与EAOC发生风险分别高2.3倍和8.3倍相关(调整后比值比分别为2.349,95%置信区间1.012 - 5.451;调整后比值比8.26,95%置信区间1.234 - 55.278)。年龄、癌症家族史和与子宫内膜异位症共存是与手术结果相关的因素。与非EAOC组相比,EAOC组更多患者接受了理想手术(分别为61.3%和41.8%),具有统计学意义。结论:年龄较小以及癌症家族史和子宫内膜异位症共存是与理想手术相关的因素。EAOC患者理想手术的成功率高于非EAOC患者。子宫内膜异位症的共存并不妨碍卵巢癌减瘤手术的成功。